The Canadian Northwest Territories have become the fifth jurisdiction to roll out a biosimilar switching policy in the country, following in the footsteps of British Columbia, Alberta, Quebec and New Brunswick.
Known as the Biosimilars Initiative, the policy will generate savings “to be reinvested to help fund coverage by increasing the...






